Skip to main content

Peer Review reports

From: Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models

Original Submission
15 Dec 2016 Submitted Original manuscript
17 Jan 2017 Reviewed Reviewer Report - Deep kamal karelia
10 Feb 2017 Reviewed Reviewer Report - Vijay Pandey
27 Feb 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 2
27 Feb 2017 Submitted Manuscript version 2
8 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 3
8 May 2017 Submitted Manuscript version 3
16 May 2017 Author responded Author comments - Vinod Burade
Resubmission - Version 4
16 May 2017 Submitted Manuscript version 4
Publishing
19 May 2017 Editorially accepted
6 Jun 2017 Article published 10.1186/s12885-017-3377-3

You can find further information about peer review here.

Back to article page